相似文献
1
Estrogens and prostate cancer: etiology, mediators, prevention, and management.
Endocrinol Metab Clin North Am. 2011 Sep;40(3):591-614, ix. doi: 10.1016/j.ecl.2011.05.002. Epub 2011 Jul 7.
2
Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates.
J Cell Biochem. 2004 Feb 15;91(3):491-503. doi: 10.1002/jcb.10759.
3
Estrogens and antiestrogens as etiological factors and therapeutics for prostate cancer.
Ann N Y Acad Sci. 2006 Nov;1089:177-93. doi: 10.1196/annals.1386.005.
4
Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
J Cell Biochem. 2007 Nov 1;102(4):899-911. doi: 10.1002/jcb.21529.
5
Steroid hormones and carcinogenesis of the prostate: the role of estrogens.
Differentiation. 2007 Nov;75(9):871-82. doi: 10.1111/j.1432-0436.2007.00224.x. Epub 2007 Oct 9.
6
The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer.
J Steroid Biochem Mol Biol. 2004 Nov;92(4):237-53. doi: 10.1016/j.jsbmb.2004.10.002. Epub 2005 Jan 5.
7
Importance of Estrogenic Signaling and Its Mediated Receptors in Prostate Cancer.
Int J Mol Sci. 2016 Aug 31;17(9):1434. doi: 10.3390/ijms17091434.
8
Estrogens and prostate cancer.
Prostate Cancer Prostatic Dis. 2019 May;22(2):185-194. doi: 10.1038/s41391-018-0081-6. Epub 2018 Aug 21.
9
Role of estrogens in development of prostate cancer.
J Steroid Biochem Mol Biol. 2004 Nov;92(4):297-305. doi: 10.1016/j.jsbmb.2004.10.016. Epub 2004 Dec 19.
10
Aromatase and prostate cancer.
Minerva Endocrinol. 2006 Mar;31(1):1-12.
引用本文的文献
1
The Pros and Cons of Estrogens in Prostate Cancer: An Update with a Focus on Phytoestrogens.
Biomedicines. 2024 Jul 23;12(8):1636. doi: 10.3390/biomedicines12081636.
2
The Role of Microbial Factors in Prostate Cancer Development-An Up-to-Date Review.
J Clin Med. 2021 Oct 18;10(20):4772. doi: 10.3390/jcm10204772.
3
The 3,4-Quinones of Estrone and Estradiol Are the Initiators of Cancer whereas Resveratrol and -acetylcysteine Are the Preventers.
Int J Mol Sci. 2021 Jul 30;22(15):8238. doi: 10.3390/ijms22158238.
4
Effects of Dietary Phytoestrogens on Hormones throughout a Human Lifespan: A Review.
Nutrients. 2020 Aug 15;12(8):2456. doi: 10.3390/nu12082456.
5
Serum Omentin Levels in Patients with Prostate Cancer and Associations with Sex Steroids and Metabolic Syndrome.
J Clin Med. 2020 Apr 20;9(4):1179. doi: 10.3390/jcm9041179.
6
Prognostic factors of survival in patients with malignant pleural mesothelioma: an analysis of the National Cancer Database.
Carcinogenesis. 2019 Jun 10;40(4):529-536. doi: 10.1093/carcin/bgz004.
7
Comparability of serum, plasma, and urinary estrogen and estrogen metabolite measurements by sex and menopausal status.
Cancer Causes Control. 2019 Jan;30(1):75-86. doi: 10.1007/s10552-018-1105-1. Epub 2018 Dec 1.
8
Molecular mechanisms involving prostate cancer racial disparity.
Am J Clin Exp Urol. 2017 Nov 9;5(3):34-48. eCollection 2017.
9
Bisphenol A and its analogues disrupt centrosome cycle and microtubule dynamics in prostate cancer.
Endocr Relat Cancer. 2017 Feb;24(2):83-96. doi: 10.1530/ERC-16-0175. Epub 2016 Dec 20.
10
Estrogen Exhibits a Biphasic Effect on Prostate Tumor Growth through the Estrogen Receptor β-KLF5 Pathway.
Mol Cell Biol. 2015 Oct 19;36(1):144-56. doi: 10.1128/MCB.00625-15. Print 2016 Jan 1.
本文引用的文献
1
Dietary soy and tea mitigate chronic inflammation and prostate cancer via NFκB pathway in the Noble rat model.
J Nutr Biochem. 2011 May;22(5):502-10. doi: 10.1016/j.jnutbio.2010.04.006.
2
Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer.
J Urol. 2010 Oct;184(4):1316-21. doi: 10.1016/j.juro.2010.06.022. Epub 2010 Aug 17.
3
Evidence for geographical and racial variation in serum sex steroid levels in older men.
J Clin Endocrinol Metab. 2010 Oct;95(10):E151-60. doi: 10.1210/jc.2009-2435. Epub 2010 Jul 28.
4
Estrogen receptor beta and the progression of prostate cancer: role of 5alpha-androstane-3beta,17beta-diol.
Endocr Relat Cancer. 2010 Jul 28;17(3):731-42. doi: 10.1677/ERC-10-0032. Print 2010 Sep.
5
Emerging research on equol and cancer.
J Nutr. 2010 Jul;140(7):1369S-72S. doi: 10.3945/jn.109.118323. Epub 2010 May 26.
6
Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen.
Prostate. 2010 Jul 1;70(10):1127-33. doi: 10.1002/pros.21147.
7
Estrogen receptor beta2 and beta5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion.
Endocr Relat Cancer. 2010 Jun 25;17(3):675-89. doi: 10.1677/ERC-09-0294. Print 2010 Sep.
8
The role of estrogen receptor beta (ERbeta) in malignant diseases--a new potential target for antiproliferative drugs in prevention and treatment of cancer.
Biochem Biophys Res Commun. 2010 May 21;396(1):63-6. doi: 10.1016/j.bbrc.2010.02.144.
9
Estrogen receptor mutations and changes in downstream gene expression and signaling.
Clin Cancer Res. 2010 May 15;16(10):2702-8. doi: 10.1158/1078-0432.CCR-09-1753. Epub 2010 Apr 28.
10
ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading.
Cancer Cell. 2010 Apr 13;17(4):319-32. doi: 10.1016/j.ccr.2010.02.030.
Zotero 插件